Ñî¹óåú´«Ã½Ò•îl

GLP-1 receptor agonist use was associated with a lower risk of death in cancer patients with brain metastases and type 2 diabetes, a retrospective cohort study found. (Monaco, 3/11)

While overall cancer incidence among women who used medically assisted reproduction wasn't elevated, certain cancers were more common in this population, an Australian population-based cohort study showed. (Robertson, 3/10)

Sentinel node biopsy (SNB) significantly reduced the risk of death from melanoma, results from a systematic review and meta-analysis indicated. (Bassett, 3/9)

A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the main goal, a blow to the company’s effort to develop a next-generation hormone therapy that sent its shares lower. Patients treated with Roche’s giredestrant and an older drug developed by Pfizer Inc. were no more likely to live without their cancer worsening than those given standard therapy, the Swiss drugmaker said Monday. (Kinzelmann, 3/9)

Incidence of pediatric inflammatory bowel disease (IBD) in one region of Denmark nearly quadrupled over four decades, according to a new population-based cohort study. (McCreary, 3/5)